Page last updated: 2024-08-24

rhodamine 123 and epirubicin

rhodamine 123 has been researched along with epirubicin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davey, MW; Davey, RA; Kidman, AD; Marks, DC1
Efferth, T; Frosini, M; Kadioglu, O; Saeed, ME; Sgaragli, G; Valoti, M1
Bie, B; Duan, B; Guo, Y; Huang, C; Li, J; Li, Z; Sun, J; Yang, J; Yang, S; Zhou, R1

Other Studies

3 other study(ies) available for rhodamine 123 and epirubicin

ArticleYear
Expression of multidrug resistance in response to differentiation in the K562 human leukaemia cell line.
    Biochemical pharmacology, 1995, Aug-08, Volume: 50, Issue:4

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Butyrates; Butyric Acid; Cell Differentiation; Cell Survival; Colchicine; Drug Resistance, Multiple; Epirubicin; Humans; Leukemia; Phenotype; Rhodamine 123; Rhodamines; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Verapamil

1995
Interactions of human P-glycoprotein transport substrates and inhibitors at the drug binding domain: Functional and molecular docking analyses.
    Biochemical pharmacology, 2016, Mar-15, Volume: 104

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Cell Culture Techniques; Cell Line, Tumor; Cyclohexanols; Epirubicin; Esters; Mice; Molecular Docking Simulation; Molecular Structure; Protein Binding; Protein Transport; Rhodamine 123; Substrate Specificity; Transfection

2016
Baicalein sensitizes hepatocellular carcinoma cells to 5-FU and Epirubicin by activating apoptosis and ameliorating P-glycoprotein activity.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 98

    Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autophagy; bcl-X Protein; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cytoprotection; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Flavanones; Fluorouracil; Hepatocytes; Humans; Liver Neoplasms; Rhodamine 123; Transcription, Genetic

2018